Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma
Year: 2023
Type: article
Study design: Clinical Trial
DOI: 10.1111/ajco.13932
Authors: Yoon Jung Jang, Sang Moo Lim, Inki Lee, Byung Hyun Byun, Ilhan Lim, Byung Il Kim, Chang Woon Choi, Seung‐Sook Lee, Cheolwon Suh, Dok Hyun Yoon, Inho Kim, Seung‐Hyun Nam, Mark Hong Lee, Jong Ho Won, Jee Hyun Kong, Seong Hyun Jeong, Suk Joong Oh, Keon Woo Park, Jae Joon Han, Moo‐Kon Song, Sung Hyun Yang, Im Il Na, Hyo‐Rak Lee, Dong‐Yeop Shin, Hye Jin Kang
Institutions: Korea Institute of Radiological and Medical Sciences, Asan Medical Center, University of Ulsan, Seoul National University, Seoul National University Hospital, Kyung Hee University, Kyung Hee University Hospital at Gangdong, Konkuk University Medical Center, Soonchunhyang University, Soonchunhyang University Hospital Seoul, Yonsei University, Wonju Severance Christian Hospital, Ajou University, Kangbuk Samsung Hospital, Sungkyunkwan University, Dankook University Hospital, Dankook University, Kyung Hee University Medical Center, Changwon Hanmaeum Hospital, Hanyang University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4324128694